Need professional-grade analysis? Visit stockanalysis.com
$15.67B
77.71
1,913
0.63%
Shenzhen Kangtai Biological Products Co Ltd (300601) trades on SHE in CNY. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at CNY14.07, down 1.19% from the previous close.
Over the past year, 300601 has traded between a low of CNY13.45 and a high of CNY20.49. The stock has gained 1.7% over this period. It is currently 31.3% below its 52-week high.
Shenzhen Kangtai Biological Products Co Ltd has a market capitalization of $15.67B, with a price-to-earnings ratio of 77.71 and a dividend yield of 0.63%.
Shenzhen Kangtai Biological Products Co., Ltd. researches and develops, produces, and sells various types of human vaccines in China. The company's marketed vaccines include 13-valent pneumococcal polysaccharide conjugate vaccine, varicella vaccine, freeze-dried, hepatitis B vaccine, inflammatory vaccine, 23-valent pneumococcal polysaccharide vaccine, DTAP/HIB combined vaccine, diphtheria, tetanus and acellular pertussis combined vaccine, adsorbed, rabies vaccine (human diploid cell) for human use, hib conjugate vaccine, measles and rubella combined vaccine, sars-cov-2 vaccine, inactivated, and covid-19 vaccine. Its research and development vaccines comprise measles, mumps and rubella vaccine, 2DTAP- HIB-IPV, 4-valent influenza (split), poliomyelitis vaccine (vero cells), and inactivated, sabin strain. Shenzhen Kangtai Biological Products Co., Ltd. was founded in 1992 and is headquartered in Shenzhen, China.
Side-by-side comparison against top Healthcare peers.